or perhaps with the stella results since last agm...
"I have a question for the Chairman, does he still consider apricitabine to be "perhaps the top clinical jewel in the Australian biotech industry", or with the ATC's stella results over the last year, is the Chairman now sure of this assessment"
- Forums
- ASX - By Stock
- AVX
- agm
agm, page-9
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)